ANIXA BIOSCIENCES, INC. Fair Value Adjustment of Warrants
ANIXA BIOSCIENCES, INC. (ANIX) reported Fair Value Adjustment of Warrants of $513.11 thousand for the 12-month period ending 2014-10-31, per its 10-K filed 2015-12-23.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2015-12-23
- ANIXA BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2014-10-31 was -$10.00.
- ANIXA BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2014-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2014-04-30 was $0.00.
- ANIXA BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2014-01-31 was $513.12K.
- ANIXA BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2014 was $513.11K, a 138.86% increase from fiscal 2013.
- ANIXA BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2013 was $214.82K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2014-10-31 | -$10.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | -$10.00 derived: sum of 2 quarters · filed 2015-12-23 | -$10.00 derived: sum of 3 quarters · filed 2015-12-23 | $513.11K 10-K · filed 2015-12-23 | ||
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $0.00 derived: sum of 2 quarters · filed 2015-08-18 | $513.12K 10-Q · filed 2015-08-18 | $513.11K 10-Q · filed 2014-09-15 | $513.12K derived: sum of 4 quarters · filed 2015-08-18 | |
| 2014-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $513.12K 10-Q · filed 2015-05-22 | $513.11K 10-Q · filed 2014-06-16 | $513.12K derived: sum of 3 quarters · filed 2015-05-22 | $513.12K derived: sum of 4 quarters · filed 2015-05-22 | |
| 2014-01-31 | $513.12K 10-Q · filed 2015-03-09 | $513.12K derived: sum of 2 quarters · filed 2015-03-09 | $513.12K derived: sum of 3 quarters · filed 2015-03-09 | |||
| 2013-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $0.00 derived: sum of 2 quarters · filed 2015-01-29 | $214.82K 10-K · filed 2015-01-29 | |||
| 2013-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $214.82K 10-Q · filed 2014-09-15 | ||||
| 2013-04-30 | $214.82K 10-Q · filed 2014-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |